Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Rogers Corp. (NY: ROG)
46.96 USD  UNCHANGED
Official Closing Price  /  Updated: 6:40 PM EDT, May 20, 2013  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 88,877
Open 47.28
Bid (Size) 42.82 (100)
Ask (Size) 51.14 (800)
Prev. Close 46.96
Today's Range 46.41 - 47.59
52wk Range 34.61 - 51.96
Shares Outstanding 17,071,336
Dividend Yield N/A
Top News
More News
Regeneron settles all pending litigation with Roche's Genentech
May 20, 2013
May 20 (Reuters) - Regeneron Pharmaceuticals Inc said it settled all pending litigation with Roche Holding AG's unit Genentech on the company's eye drug, Eylea, and cancer drug, Zaltrap. Read More
category companyNews
from Reuters: Company News
Pfizer halts study of lymphoma drug unlikely to help survival
May 20, 2013
May 20 (Reuters) - Pfizer Inc, which has been on a hot streak with three recent approvals of cancer drugs, stumbled on Monday, saying it was halting a late-stage trial of a drug for aggressive... Read More
category companyNews
from Reuters: Company News

More News
Read More
CORRECTED-Data show new Roche leukemia drug may improve on Rituxan
May 16, 2013
category companyNews
from Reuters: Company News
DEALTALK-Novartis' Vasella exit opens door to Roche stake sale
May 16, 2013
category companyNews
from Reuters: Company News
RPT-Market Chatter-Corporate finance press digest
May 16, 2013
category companyNews
from Reuters: Company News
Market Chatter-Corporate finance press digest
May 16, 2013
category companyNews
from Reuters: Company News
Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer
May 15, 2013
from Business Wire News Releases
Roche immunotherapy shows response over range of cancers
May 15, 2013
category companyNews
from Reuters: Company News
New cancer tools allow patients to reconsider chemo
May 15, 2013
category companyNews
from Reuters: Company News
Data shows new Roche leukemia drug may improve on Rituxan
May 15, 2013
category companyNews
from Reuters: Company News
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here